Clinical Trial Update: High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating high-dose thiotepa followed by peripheral stem cell transplantation in patients with refractory solid tumors, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Central Nervous System Tumors
• Childhood Germ Cell Tumors
• Extragonadal Germ Cell Tumors
• Ovarian Cancer
• Retinoblastoma
• Testicular Germ Cell Tumors

Drugs mentioned

• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 2 | Status: COMPLETED